Aptahem AB (publ) (NGM:APTA)
0.5260
+0.0260 (5.20%)
At close: Sep 3, 2026
Aptahem AB Revenue
Aptahem AB had revenue of 342.00K SEK in the quarter ending June 30, 2026, a decrease of -56.54%. This brings the company's revenue in the last twelve months to -537.00K. In the year 2025, Aptahem AB had annual revenue of 2.59M, down -32.73%.
Revenue (ttm)
-537.00K
Revenue Growth
-32.73%
P/S Ratio
-25.40
Revenue / Employee
-179.00K
Employees
3
Market Cap
13.64M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.59M | -1.26M | -32.73% |
| Dec 31, 2024 | 3.84M | -6.62M | -63.28% |
| Dec 31, 2023 | 10.46M | 7.02M | 203.47% |
| Dec 31, 2022 | 3.45M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 275.79M |
| ExpreS2ion Biotech Holding AB | 24.25M |
| Fluicell AB | 22.19M |
| AcouSort AB | 9.31M |
| OncoZenge AB | 5.97M |
| Biosergen AB | 2.09M |
| NanoEcho AB | 1.13M |
| Alligator Bioscience AB | 681.00K |
Aptahem AB News
- 8 days ago - Aptahem AB Quarterly report: Q2 2026 - Filings
- 3 months ago - Aptahem AB Quarterly report: Q1 2026 - Filings
- 6 months ago - Aptahem AB Annual report: Q4 2025 - Filings
- 6 months ago - Aptahem AB Quarterly report: Q4 2025 - Filings
- 9 months ago - Aptahem AB Quarterly report: Q3 2025 - Filings
- 10 months ago - Aptahem AB Transcript: Status Update - Transcripts
- 10 months ago - Aptahem AB Press release: Status Update - Filings
- 11 months ago - Aptahem AB Press release: Status Update - Filings